酒石酸美托洛尔片联合辛伐他汀片治疗冠心病心绞痛的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Metoprolol Tartrate Tablets combined with Simvastatin Tablets in the treatment of angina pectoris in patients with coronary heart disease (CHD). Methods Altogether 158 patients with angina pectoris of CHD treated in our hospital from January to December 2018 were selected as the research objects and divided into control group (79 cases) and observation group (79 cases) by random number table method.The control group was treated with Metoprolol Tartrate Tablets alone. The observation group was treated with Simvastatin Tablets combined with Metoprolol Tartrate Tablets. The clinical treatment indicators, therapeutic indicators and total incidence of adverse reactions were compared between the two groups. Results At the end of treatment, the number of attacks in the observation group was fewer than that in the control group, the duration of angina pectoris in the observation group was shorter than that in the control group, the matrix metalloproteinase-9 (MMP-9), matrix metalloproteinase-2 (MMP-2) and the total incidence of adverse reactions in the observation group were lower than those in the control group, with statistically significant differences (P＜0.05). The mouse anti-human tissue inhibitors of metalloproteinases-1 (TIMP-1), serum vascular endothelial growth factor (VEGF) and total effective rate in the observation group were higher than those in the control group, with statistically significant differences (P＜0.05). Conclusion Simvastatin Tablets combined with Metoprolol Tartrate Tablets can effectively improve the prognosis of patients with angina pectoris of coronary heart disease, which is worth popularizing.

Key words： Coronary heart disease Simvastatin Tablets Metoprolol Tartrate Tablets Angina pectoris

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Ban

Cite this article:

LIU Ban. Effect of Metoprolol Tartrate Tablets combined with Simvastatin Tablets in treatment of angina pectoris in patients with coronary heart disease[J]. 中国当代医药, 2020, 27(6): 79-81.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I6/79

[1]	庄晓华，傅咏华，凌佳，等.麝香通心滴丸联合美托洛尔治疗冠心病心绞痛的疗效观察[J].现代药物与临床，2018，33（5）：1052-1055.
[2]	张赟，许丽雯.缬沙坦联合美托洛尔治疗原发性高血压合并冠心病的疗效观察[J].中西医结合心脑血管病杂志，2016，14（2）：173-175.
[3]	陈金红，李建军，倪蓓，等.益气活血汤对气虚血瘀型冠心病心绞痛患者心功能的影响及作用机制研究[J].四川中医，2018，36（2）：79-82.
[4]	张春蓉.参松养心胶囊对冠状动脉粥样硬化性心绞痛失眠患者心肌保护作和睡眠质量的影响[J].中医学报，2018，33（2）：303-306.
[5]	景月月.通心络胶囊联合辛伐他汀治疗冠心病不稳定型心绞痛疗效及对血清hs-CRP、IL-6 水平的影响[J].现代中西医结合杂志，2017，26（35）：3959-3961.
[6]	林玲，何五建，陆士奇，等.辛伐他汀片联合硫酸氢氯吡格雷片治疗不稳定型心绞痛的临床研究[J].中国临床药理学杂志，2017，33（22）：2222-2225.
[7]	任小娟，祝婕，张秀芬，等.雪莲通脉丸对冠心病心绞痛患者血管内皮影响的临床研究[J].世界中医药，2017，12（9）：1993-1996.
[8]	胡俊兴.冠心宁注射液联合美托洛尔治疗冠心病心绞痛的疗效观察[J].现代药物与临床，2017，32（8）：1449-1453.
[9]	王博，吴松，谢俊.电针治疗心血瘀阻型冠心病心绞痛的临床观察[J].湖北中医药大学学报，2017，19（3）：77-80.
[10]	任智敏.丹参川芎嗪注射液联合美托洛尔治疗冠心病心绞痛的疗效观察[J].现代药物与临床，2016，31（11）：1712-1715.
[11]	何薇，石元龙，郑成根.丹参酮ⅡA 磺酸钠联合辛伐他汀治疗冠心病心绞痛的临床研究[J].中国临床药理学杂志，2016，32（5）：393-395.
[12]	伍红艳，汤磊.银丹心泰滴丸治疗冠心病心绞痛的成本-效益分析[J].中国药房，2016，27（5）：577-580.
[13]	李智，李庆淑，于俊.美托洛尔剂型选择对老年不稳定型心绞痛患者心率变异性及QT 间期离散度的影响分析[J].中国循证心血管医学杂志，2016，8（2）：186-188.
[14]	李军朋，高爱红，刘积伦，等.美托洛尔联合辛伐他汀治疗老年不稳定型心绞痛患者的效果及对CRP、BNP 水平的影响[J].疑难病杂志，2016，15（2）：139-142.
[15]	付盈菊，刘志宁，宋玉新.酒石酸美托洛尔片联合辛伐他汀片治疗冠心病心绞痛的临床研究[J].中国临床药理学杂志，2018，34（8）：922-925.